Theravance Biopharma (TBPH) Stock Chart & Stock Price History $9.50 0.00 (-0.04%) As of 10:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Theravance Biopharma Stock Price Performance 5 Day Performance-0.42%1 Month Performance+2.93%3 Month Performance-1.35%6 Month Performance+9.83%Year-To-Date Performance+0.96%1 Year Performance+5.67% Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address TBPH Stock Chart for Wednesday, April, 30, 2025 TBPH Chart by TradingView Theravance Biopharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2025$9.75$9.50-2.56%$9.74$9.49223,966 shs$475.01 million04/28/2025$9.75$9.75$9.80$9.62187,457 shs$487.51 million04/25/2025$9.54$9.75+2.20%$9.75$9.42215,186 shs$487.51 million04/24/2025$9.45$9.54+0.95%$9.56$9.33258,760 shs$477.01 million04/23/2025$9.31$9.45+1.50%$9.51$9.30184,153 shs$472.51 million04/22/2025$9.13$9.31+1.97%$9.36$9.12217,628 shs$465.51 million04/21/2025$8.62$9.13+5.92%$9.18$8.52304,436 shs$456.51 million04/18/2025$8.62$8.62$8.69$8.51160,020 shs$431.01 million04/17/2025$8.60$8.62+0.23%$8.69$8.51160,020 shs$431.01 million04/16/2025$8.63$8.60-0.35%$8.69$8.44194,569 shs$425.45 million Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 04/15/2025$8.73$8.63-1.15%$8.82$8.52227,892 shs$426.94 million04/14/2025$8.40$8.73+3.93%$8.78$8.31243,265 shs$431.88 million04/11/2025$8.39$8.40+0.12%$8.64$8.16148,962 shs$415.56 million04/10/2025$8.53$8.39-1.64%$8.43$8.12200,446 shs$415.06 million04/09/2025$8.32$8.53+2.52%$8.81$8.09375,245 shs$421.99 million04/09/2025$8.32$8.53+2.52%$8.81$8.09375,245 shs$421.99 million04/08/2025$8.41$8.32-1.07%$9.16$8.23274,794 shs$411.60 million04/08/2025$8.41$8.32-1.07%$9.16$8.23274,794 shs$411.60 million04/07/2025$8.44$8.41-0.36%$8.66$7.90275,529 shs$416.05 million04/04/2025$8.77$8.44-3.76%$8.64$8.33218,939 shs$417.54 million04/03/2025$9.01$8.77-2.66%$9.08$8.65213,671 shs$433.86 million04/02/2025$9.02$9.01-0.11%$9.20$8.77236,352 shs$445.73 million04/01/2025$8.93$9.02+1.01%$9.09$8.72255,205 shs$446.23 million03/31/2025$9.23$8.93-3.25%$9.15$8.93376,303 shs$441.78 million03/28/2025$9.31$9.23-0.86%$9.42$9.18135,276 shs$456.62 million Related Companies NAMS Stock Price Chart BLTE Stock Price Chart BHC Stock Price Chart JANX Stock Price Chart SUPN Stock Price Chart AAPG Stock Price Chart ARWR Stock Price Chart HRMY Stock Price Chart GLPG Stock Price Chart CNTA Stock Price Chart Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBPH) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersYou’re About to Lose Everything – Act Now or Regret It ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theravance Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TBPH Stock Free TBPH Stock Alerts